What is the global market size of Neurodiagnostics Market?

Global Neurodiagnostics Market size was valued at USD 7.45 billion in 2022 and is poised to grow from USD 7.97 billion in 2023 to USD 13.70 billion by 2031, growing at a CAGR of 7% during the forecast period (2024-2031).

What is the key driver of Global Neurodiagnostics Market?

The rising prevalence of neurological disorders, such as Alzheimer's disease, Parkinson's disease, and epilepsy, is a major driver for the neurodiagnostics market. As the global population ages and lifestyles change, the burden of neurological disorders is increasing. This drives the demand for neurodiagnostic procedures to accurately diagnose and monitor these conditions.

What is the key market trend for Global Neurodiagnostics Market?

Integration of Data Analytics and Cloud Computing: The integration of data analytics and cloud computing in neurodiagnostics is gaining traction. The ability to store and analyze large volumes of patient data in the cloud enables efficient data management, remote collaborations, and the development of predictive models for better diagnosis and treatment planning. This trend promotes data-driven decision-making and personalized patient care in neurodiagnostics.

Which region accounted for the largest share in Global Neurodiagnostics Market?

North America emerges as the dominating region in the global neurodiagnostics market. The region's dominance can be attributed to several factors, including advanced healthcare infrastructure, robust research and development activities, and high healthcare expenditure. North America is home to numerous prominent neurodiagnostic device manufacturers, research institutes, and academic centers specializing in neurological disorders. Moreover, the region experiences a high prevalence of neurological conditions, driving the demand for neurodiagnostic procedures. The presence of well-established healthcare systems, reimbursement frameworks, and skilled healthcare professionals further contribute to the dominance of North America in the neurodiagnostics market.

Top Neurodiagnostics Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Neurodiagnostics Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Neurodiagnostics industry players.

Neurodiagnostics Market Competitive Landscape

The global neurodiagnostics market features a competitive landscape with several key players vying for market share and striving for innovation in the field of neurological diagnostics. These companies focus on developing advanced neurodiagnostic devices, expanding their product portfolios, and strengthening their distribution networks to gain a competitive edge. The competitive landscape is characterized by a mix of established multinational corporations and emerging players specializing in neurodiagnostics. Collaborations, partnerships, and mergers and acquisitions are common strategies adopted by companies in the neurodiagnostics market. These collaborations enable knowledge sharing, technology transfer, and market expansion. Moreover, partnerships with academic institutions, research centers, and healthcare providers facilitate clinical trials, data collection, and validation of neurodiagnostic devices.

Neurodiagnostics Market Top Player’s Company Profiles

Siemens Healthineers (Germany)

GE Healthcare (US)

Philips Healthcare (Netherlands)

Medtronic (Ireland)

Hitachi Medical Corporation (Japan)

Natus Medical Incorporated (US)

Abbott Laboratories (US)

Koninklijke Philips N.V. (Netherlands)

Thermo Fisher Scientific Inc. (US)

Elekta AB (Sweden)

Brainlab AG (Germany)

Masimo Corporation (US)

Cadwell Industries Inc. (US)

Advanced Brain Monitoring, Inc. (US)

Compumedics Limited (Australia)

Neurosoft Ltd. (Russia)

Magstim (UK)

NeuroWave Systems Inc. (US)

BrainScope Company Inc. (US)

Blackrock Microsystems LLC (US)

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?

REQUEST FREE CUSTOMIZATION

FAQs

Neurodiagnostics Market size was valued at USD 10.79 Billion in 2024 and is poised to grow from USD 11.76 Billion in 2025 to USD 23.43 Billion by 2033, growing at a CAGR of 9% during the forecast period (2026–2033).

Some of the key players in the neurodiagnostic market include Siemens Healthineers, GE Healthcare, Philips Healthcare, and Abbott Laboratories, and new entrants, who are predicted to be future leaders in the industry and are utilizing advanced technologies. These companies focus on strengthening their presence in the above market primarily by forming strategic alliances, mergers and acquisitions and by new product development. This is being pushed forward within healthcare organizations as artificial intelligence, imaging and genetic testing technologies evolve where organizations are looking for more precise, cheaper and quicker ways of diagnosing patients. 'Siemens Healthineers (Germany)', 'Thermo Fisher Scientific (US) ', 'GE Healthcare (US) ', 'Koninklijke Philips (Netherlands) ', 'FUJIFILM (Japan) ', 'Lifelines Neuro (US) ', 'Advanced Brain Monitoring (US) ', 'Nihon Kohden (Japan) ', 'Hoffmann-La Roche (Switzerland) ', 'Canon Medical Systems (Japan) ', 'Danaher (US) ', 'Abbott Laboratories (US) ', 'Becton, Dickinson and Company (BD) (US) ', 'Johnson & Johnson (US) ', 'Medtronic (Ireland) ', 'Stryker (US) ', 'Intuitive Surgical (US) ', 'Zimmer Biomet (US) ', 'Smith & Nephew (UK)'

The main reason for market growth in neurodiagnostic is the mounting incidence of neurological conditions such as epilepsy, Parkinson's, and Alzheimer's. Neurodiagnostic technologies are increasingly being adopted in healthcare facilities as the demand for sophisticated diagnostic instrumentation to identify and track these disorders increases with the increased number of afflicted individuals.

Genomics and Personalized Medicine: The proteomics and genomics revolution, which is aiding the healing of neurological disorders, is the current market trend in personalization medicine. By examining an individual’s genetic code, the physician can provide more targeted and efficacious treatments enhancing that individual’s care. Therefore, this trend in the neurodiagnostic sector is leaning towards the utilization of sophisticated diagnostic techniques.

Revenue share of the market in 2023 was occupied by North America with a dominating share of 35.8%. Many factors, such as a mature healthcare infrastructure, research and development initiatives, and health expenditures, contribute to this regional dominance. For instance, the 159-bed Indiana NeuroDiagnostic Institute and Advanced Treatment Center, NDI, which costs USD 120 million, opened in March 2019. Traumatic brain injury, neurodegenerative disorders such as Alzheimer's disease, acute and chronic mental illness, among others, are treated by the institution. Neurological conditions also happen to be relatively prevalent in the region; therefore, the more pressing need for neurodiagnostic arises.

Top Neurodiagnostics Companies

Neurodiagnostics Market Competitive Landscape

FAQs

What is the global market size of Neurodiagnostics Market?

Who are the key vendors in the Neurodiagnostics Market?

What is the key driver of Neurodiagnostics Market?

What is the key market trend for Neurodiagnostics Market?

Which region accounted for the largest share in Neurodiagnostics Market?

Request Free Customization